TITLE

A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up

AUTHOR(S)
Politi, Luigi; Sgura, Fabio; Rossi, Rosario; Monopoli, Daniel; Guerri, Elisa; Leuzzi, Chiara; Bursi, Francesca; Sangiorgi, Giuseppe Massimo; Modena, Maria Grazia
PUB. DATE
May 2010
SOURCE
Heart;May2010, Vol. 96 Issue 9, p662
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background Few reports described outcomes of complete compared with infarct-related artery (IRA)-only revascularisation in patients with ST-elevation myocardial infarction (STEMI) and multivessel coronary artery disease (CAD). Moreover, no studies have compared the simultaneous treatment of non-IRA with the IRA treatment followed by an elective procedure for the other lesions (staged revascularisation). Methods The outcomes of 214 consecutive patients with STEMI and multivessel CAD undergoing primary angioplasty were studied. Before the first angioplasty patients were randomly assigned to three different strategies: culprit vessel angioplasty-only (COR group); staged revascularisation (SR group) and simultaneous treatment of non-IRA (CR group). Results During a mean follow-up of 2.5 years, 42 (50.0%) patients in the COR group experienced at least one major adverse cardiac event (MACE), 13 (20.0%) in the SR group and 15 (23.1%) in the CR group, p<0.001. Inhospital death, repeat revascularisation and re-hospitalisation occurred more frequently in the COR group (all p<0.05), whereas there was no significant difference in re-infarction among the three groups. Survival free of MACE was significantly reduced in the COR group but was similar in the CR and SR groups. Conclusions Culprit vessel-only angioplasty was associated with the highest rate of long-term MACE compared with multivessel treatment. Patients scheduled for staged revascularisation experienced a similar rate of MACE to patients undergoing complete simultaneous treatment of non-IRA.
ACCESSION #
52086656

 

Related Articles

  • Access to myocardial revascularization procedures: Closing the gap with time? Vanasse, Alain; Niyonsenga, Théophile; Courteau, Josiane; Hemiari, Abbas // BMC Public Health;2006, Vol. 6 Issue 1, p1 

    Background: Early access to revascularization procedures is known to be related to a more favorable outcome in myocardial infarction (MI) patients, but access to specialized care varies widely amongst the population. We aim to test if the early gap found in the revascularization rates, according...

  • The Role of Coronary Angioplasty in the Management of Patients with Stable Coronary Artery Disease. Katritsis, Demosthenes G. // Cardiovascular & Haematological Disorders - Drug Targets;Mar2007, Vol. 7 Issue 1, p15 

    A review of the existing evidence on the impact of percutaneous coronary intervention (PCI) in the setting of stable coronary artery disease (CAD) indicates that in patients with chronic coronary artery disease and good left ventricular function, PCI does not confer any clear benefit in terms of...

  • A Randomized Study of Coronary Angioplasty Compared with Bypass Surgery in Patients with Symptomatic Multivessel Coronary Disease. Hamm, Christian W.; Reimers, Jacobus; Ischinger, Thomas; Rupprecht, Hans-Jurgen; Berger, Jurgen; Bleifeld, Walter // New England Journal of Medicine;10/20/94, Vol. 331 Issue 16, p1037 

    Background: The standard treatment for patients with symptomatic multivessel coronary artery disease is coronary-artery bypass grafting (CABG). Percutaneous transluminal coronary angioplasty (PTCA) is widely used as an alternative approach to revascularization, but a systematic comparison of the...

  • A Randomized Study of Coronary Angioplasty Compared with Bypass Surgery in Patients with Symptomatic Multivessel Coronary Disease. Hamm, Christian W.; Reimers, Jacobus; Ischinger, Thomas; Rupprecht, Hans-Jurgen; Berger, Jurgen; Bleifeld, Walter // New England Journal of Medicine;10/20/94, Vol. 331 Issue 16, p1037 

    Background: The standard treatment for patients with symptomatic multivessel coronary artery disease is coronary-artery bypass grafting (CABG). Percutaneous transluminal coronary angioplasty (PTCA) is widely used as an alternative approach to revascularization, but a systematic comparison of the...

  • Myocardial Revascularization for Acute and Chronic Coronary Heart Disease. Swan, H. J. C.; Chatterjee, Kanu; Corday, Eliot; Ganz, William; Marcus, Harold; Matloff, Jack; Parmley, William // Annals of Internal Medicine;Dec73, Vol. 79 Issue 6, p851 

    Discusses the use of myocardial revascularization for acute and chronic coronary heart disease. Indications for myocardial revascularization; Indications for bypass surgery; Hemodynamic and angiographic evaluation of candidates for myocardial revascularization; Selection of patients for...

  • COMMENTARY: An early invasive strategy improved long-term freedom from major adverse cardiac events in older patients with angina. Borzak, Steven // ACP Journal Club;Mar/Apr2005, Vol. 142 Issue 2, p39 

    The article reports that an early invasive strategy improved long-term freedom from major adverse cardiac events in older patients with angina. Patients who received revascularization within the first year, either because of randomization to the early-intervention group or because of ongoing...

  • Percutaneous coronary intervention (PCI). Mendes, Aysha // British Journal of Cardiac Nursing;May2015, Vol. 10 Issue 5, p257 

    The article provides an overview of the clinical procedure percutaneous coronary intervention (PCI) which aims to reduce the risk of heart failure in patients. Topics discussed include a description of how the procedure works, the type of patients where PCI can be safely used, and the important...

  • Non-ST Elevation Myocardial Infarction with Occluded Artery and its Clinical Implications. Soon, Kean; Du, Hao Nan; Klim, Sharon; Zakariyya, Ahmad; Kelly, Anne-Maree // Heart, Lung & Circulation;Dec2014, Vol. 23 Issue 12, p1132 

    Background This study aimed to determine the prevalence and differences between Non-ST elevation Myocardial Infarction (NSTEMI) with an occluded culprit artery (NSTEMIOA) and NSTEMI with a patent culprit artery (NSTEMIPA). Methods We conducted a retrospective observational study on NSTEMI...

  • CORONARY ARTERY DISEASE -- MYOCARDIAL INFARCTION.  // Current Medical Literature: Interventional Cardiology Monitor;2004, Vol. 11 Issue 4, p111 

    Presents reviews of literature on coronary artery disease. �Primary angioplasty in acute myocardial infarction at hospitals with no surgery on-site (the PAMI-No SOS study) versus transfer to surgical centers for primary angioplasty�; �A randomized trial of rescue angioplasty...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics